IONIS PHARMACEUTICALS INC (IONS) Stock Earnings Estimates
NASDAQ:IONS • US4622221004
80.6 USD
-1.18 (-1.44%)
At close: Feb 13, 2026
80.6 USD
0 (0%)
After Hours: 2/13/2026, 4:30:03 PM
Full estimates are only available for subscribed users, you can see which data is available below.
Subscribed users also see more surprise data, now it is restricted to 4 quarters.
Examples of complete estimate data are available for MSFT and AAPL.
Registered users have access to more data. Please register or login for additional estimates and surprises .
| 2022 | 2023 | 2024 | 2025 | 2026 | 2027 | 2028 | 2029 | 2030 | 2031 | 2032 | 2033 | ||
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Revenue YoY % growth | 587.4M -27.53% | 787.647M 34.09% | 705.138M -10.48% | 915.23M 29.79% | 919.47M 0.46% | 1.383B 50.41% | 1.848B 33.62% | 2.509B 35.77% | 3.186B 26.98% | 3.738B 17.33% | 4.304B 15.14% | 4.966B 15.38% | |
| EBITDA YoY % growth | -393.5M -3,492.24% | -320.879M 18.46% | -463.131M -44.33% | -355.44M 23.25% | -465.049M -30.84% | -111.13M 76.10% | N/A | N/A | N/A | N/A | N/A | N/A | |
| EBIT YoY % growth | -410.2M -6,411.11% | -333.73M 18.64% | -475.081M -42.35% | -381.957M 19.60% | -504.909M -32.19% | -226.077M 55.22% | 145.89M 164.53% | 632.39M 333.47% | 1.165B 84.22% | 1.382B 18.63% | 1.753B 26.85% | 1.995B 13.80% | |
| Operating Margin | -69.83% | -42.37% | -67.37% | -41.73% | -54.91% | -16.35% | 7.89% | 25.20% | 36.57% | 36.97% | 40.73% | 40.17% | |
| EPS YoY % growth | -2.89 -660.53% | -2.56 11.42% | -3.04 -18.75% | -2.31 24.14% | -3.13 -35.55% | -1.47 53.11% | 1.61 209.85% | 3.75 133.12% | 5.41 44.02% | 7.82 44.59% | 9.47 21.14% | 10.85 14.56% |
All data in USD
| Q4 / 25 | Q1 / 26 | Q2 / 26 | Q3 / 26 | Q4 / 26 | Q1 / 27 | Q2 / 27 | Q3 / 27 | Q4 / 27 | |
|---|---|---|---|---|---|---|---|---|---|
| EPS Q2Q % growth | -1.34 -102.52% | -0.78 16.65% | -0.72 -203.17% | -0.69 14.06% | -0.65 51.16% | -0.98 -26.32% | -0.83 -14.41% | -0.60 12.46% | -0.44 32.81% |
| Revenue Q2Q % growth | 158.47M -30.19% | 200.99M 52.27% | 219.1M -51.53% | 232.52M 48.10% | 242.97M 53.32% | 210.89M 4.93% | 242.96M 10.89% | 285.74M 22.89% | 318.28M 31.00% |
| EBITDA Q2Q % growth | -217.204M -119.68% | -143.562M 0.34% | -129.358M -188.91% | -131.931M 12.99% | N/A | N/A | N/A | N/A | N/A |
| EBIT Q2Q % growth | -215.025M -94.03% | -126.419M 13.92% | -120.203M -185.97% | -123.384M 22.97% | -121.019M 43.72% | N/A | N/A | N/A | N/A |
All data in USD
| Period | Reported | Estimate | Difference | Surprise |
|---|---|---|---|---|
| Q3 2025 Q2Q % growth | -0.80 15.79% | -1.26 | 0.46 | 36.42% |
| Q2 2025 Q2Q % growth | 0.70 255.56% | -0.44 | 1.14 | 259.57% |
| Q1 2025 Q2Q % growth | -0.93 5.10% | -1.14 | 0.21 | 18.36% |
| Q4 2024 Q2Q % growth | -0.66 -1,000.00% | -1.15 | 0.49 | 42.39% |
| Q3 2024 Q2Q % growth | -0.95 7.77% | -1.18 | 0.23 | 19.50% |
| Q2 2024 Q2Q % growth | -0.45 25.00% | -0.94 | 0.49 | 52.10% |
| Q1 2024 Q2Q % growth | -0.98 -12.64% | -1.07 | 0.09 | 8.61% |
| Q4 2023 Q2Q % growth | -0.06 95.59% | -0.85 | 0.79 | 92.92% |
| Q3 2023 Q2Q % growth | -1.03 -212.12% | -1.06 | 0.03 | 2.99% |
| Q2 2023 Q2Q % growth | -0.60 18.92% | -0.92 | 0.32 | 34.77% |
| Q1 2023 Q2Q % growth | -0.87 -89.13% | -0.93 | 0.06 | 6.36% |
| Q4 2022 Q2Q % growth | -1.36 -196.45% | -0.94 | -0.42 | -44.37% |
| Q3 2022 Q2Q % growth | -0.33 43.10% | -0.76 | 0.43 | 56.43% |
| Q2 2022 Q2Q % growth | -0.74 -29.82% | -0.64 | -0.10 | -16.37% |
| Q1 2022 Q2Q % growth | -0.46 28.13% | -0.73 | 0.27 | 36.60% |
| Q4 2021 Q2Q % growth | 1.41 220.45% | 0.29 | 1.12 | 391.36% |
| Q3 2021 Q2Q % growth | -0.58 -163.64% | -0.54 | -0.04 | -8.24% |
| Q2 2021 Q2Q % growth | -0.57 -147.83% | -0.61 | 0.04 | 6.57% |
| Q1 2021 Q2Q % growth | -0.64 -82.86% | -0.54 | -0.10 | -19.44% |
| Q4 2020 Q2Q % growth | 0.44 | 0.29 | 0.15 | 52.87% |
| Q3 2020 Q2Q % growth | -0.22 | -0.10 | -0.12 | -127.88% |
| Q2 2020 Q2Q % growth | -0.23 | -0.28 | 0.05 | 18.04% |
| Q1 2020 Q2Q % growth | -0.35 | -0.13 | -0.22 | -171.77% |
| Period | Reported | Estimate | Difference | Surprise |
|---|---|---|---|---|
| Q3 2025 Q2Q % growth | 157M 17.16% | 133.54M | 23.46M | 17.57% |
| Q2 2025 Q2Q % growth | 452.049M 100.69% | 301.08M | 150.969M | 50.14% |
| Q1 2025 Q2Q % growth | 132M 10.92% | 127.83M | 4.17M | 3.26% |
| Q4 2024 Q2Q % growth | 227M -30.15% | 140.36M | 86.64M | 61.73% |
| Q3 2024 Q2Q % growth | 134M -6.94% | 132.73M | 1.27M | 0.96% |
| Q2 2024 Q2Q % growth | 225.25M 19.81% | 153.07M | 72.18M | 47.15% |
| Q1 2024 Q2Q % growth | 119M -9.16% | 138.65M | -19.65M | -14.17% |
| Q4 2023 Q2Q % growth | 325M 113.96% | 178.25M | 146.75M | 82.33% |
| Q3 2023 Q2Q % growth | 144M -9.89% | 135.56M | 8.44M | 6.23% |
| Q2 2023 Q2Q % growth | 188M 40.51% | 141.6M | 46.4M | 32.77% |
| Q1 2023 Q2Q % growth | 131M -7.68% | 130.68M | 320K | 0.24% |
| Q4 2022 Q2Q % growth | 151.9M -65.48% | 161.82M | -9.92M | -6.13% |
| Q3 2022 Q2Q % growth | 159.8M 20.06% | 146.77M | 13.03M | 8.88% |
| Q2 2022 Q2Q % growth | 133.8M 6.36% | 143.33M | -9.53M | -6.65% |
| Q1 2022 Q2Q % growth | 141.9M 27.15% | 127.72M | 14.18M | 11.10% |
| Q4 2021 Q2Q % growth | 440M 51.57% | 264.33M | 175.67M | 66.46% |
| Q3 2021 Q2Q % growth | 133.1M -16.86% | 161.55M | -28.45M | -17.61% |
| Q2 2021 Q2Q % growth | 125.8M -13.54% | 139.04M | -13.24M | -9.52% |
| Q1 2021 Q2Q % growth | 111.6M -16.34% | 131.16M | -19.56M | -14.91% |
| Q4 2020 Q2Q % growth | 290.3M | 279.97M | 10.33M | 3.69% |
| Q3 2020 Q2Q % growth | 160.1M | 185.78M | -25.68M | -13.82% |
| Q2 2020 Q2Q % growth | 145.5M | 151.85M | -6.35M | -4.18% |
| Q1 2020 Q2Q % growth | 133.4M | 164.35M | -30.95M | -18.83% |
| Next Q (1 month) | Next Q (3 month) | Next Year (1 month) | Next Year (3 month) | |
|---|---|---|---|---|
| EPS | -0.98% | -1.16% | -0.05% | 2.23% |
| Revenue | 2.83% | 3.48% | 0.06% | 1.44% |